We report a case of renal papillary necrosis with diabetes mellitus which was treated with prostaglandin E l , An intravenous infusion of 40 mg/day prostaglandin E, was given for 14 days in an attempt to improve renal circulation. Treatment resulted in an improved creatinine clearance, renal plasma flow and renogram, and proteinuria was decreased, The administration of prostaglandin E 1 produced an improvement in renal haemodynamics and can be considered as a possible therapy for renal papillary necrosis in diabetic patients. KEY WORDS: DIABETES MELLITUS; PROSTAGLANDIN E,; RENAL PAPILLARY NECROSIS Prostaglandin E 1 in renal papillary necrosis Prostaglandins 1978; 16: 373 -388. 16 Okada S, Sato K, Ichiki K, et al: Influence of prostaglandin E, on slight proteinuria in non-azotemic diabetics. J Ini Med Res
INTRODUCTION
Renal papillary necrosis (RPN) is characterized by a particular form of renal damage in which any or all of the papillae undergo selective necrosis in a manner that can be demonstrated radiologically or histologically. The clinical features of this disease include acute renal failure, obstruction by a sloughed papilla, haematuria, loin pain, passage of tissue in the urine, and recurrent or severe urinary tract infection. The pathogenesis of RPN can be 90 multifactorial: vascular diseases, infection, urinary and vascular obstruction and drug toxicity can be present singly or in combination, leading to the necrosis of papillae. Ischaemia is believed to be a final common pathway by which all the known factors lead to RPN. The primary treatment for RPN has been to control the associated condition(s) leading to RPN; however, there is no constitutional therapy for RPN, especially when it is associated with diabetes mellitus. 
Prostaglandin E 1 in renal papillary necrosis
Prostaglandin E, is a potent vasodilator and inhibitor of platelet aggregation that has been used with apparent benefit in patients with ischaemic vascular diseases.':" This report describes the clinical efficacy of prostaglandin E. infusion in a patient with RPN and diabetes mellitus. We have decided to report this case after a lengthy delay since, in the intervening years there has been an increasing number of reports of cases of RPN associated with diabetes mellitus, and we believe that the present report may help others to determine the appropriate therapeutic strategy for such patients.
CASE REPORT
A 65-year-old woman was admitted to hospital on 2 September 1989 after an episode of gross haematuria followed by sudden severe left flank and back pain. She also complained of nausea and vomiting but not of dysuria, frequency or urgency. Her family history was unremarkable. She had no history of sickle cell anaemia and liver dysfunction. She did not take acetaminophen, non-steroidal anti-inflammatory drugs, or any recreational drugs. She had a 10-year history of diabetes mellitus and took 2.5 mg sulphonylurea every day. She had undergone retinal laser photocoagulation for the treatment of diabetic retinopathy with microaneurysm in 1984. The patient was 152 cm tall and weighed 59 kg; her blood pressure was 152/72 mmHg, her pulse rate, 76 bpm and her body temperature, 37.5°C. The patient was not anaemic and her eyelid and eyeball conjunctiva were free of any signs of jaundice; her heart and respiratory sounds were normal. There was left-sided costovertebral tenderness to percussion. Vibratory sense and the deep tendon reflex of the extremities were slightly decreased. No pretibial oedema was detected. Funduscopic examination revealed diabetic retinopathy 91 with microaneurysm (Scott classification IIIb). Laboratory data at admission were as follows: haemoglobin 13.2 g/dl; white blood cell count 21,300/mm 3 with 80% polymorphonuclear leukocytes; erythrocyte sedimentation rate 70 mm/h; blood urea nitrogen 4.9 mg/dl; serum creatinine 0.9 mg/dl; 24-h creatinine clearance 26.5 l/day; renal plasma flow 242 ml/min; lactate hydrogenase 476 mU/ml (normal range; 202 -435); glucose 185 mg/dl; and haemoglobin Ale 7.5%. Other biochemical analyses were not remarkable.
Urinalysis on admission revealed 3+ proteinuria, 3+ haematuria, and pyuria. The patient's urine culture was negative on three separate occasions. Serological investigations were negative for anti-nuclear and antideoxyribonucleic acid (anti-DNA) antibodies. Lupus Erythematosus test and circulating immune complexes were also negative. Serum levels of complements C3 and C4 were normal.
Abdominal computed tomographic scan revealed a low-density area on the left kidney; however, selective renal angiography showed no evidence of renal infarction. Renal ultrasonography demonstrated a low echo genic region in the central renal pelvis and hydronephrosis. Retrograde pyelography ofthe left kidney revealed clubbing of several calices, extravasation from the lower calices to the renal parenchyma, and hydronephrosis of the left kidney (Fig. 1) . The renogram of the left kidney had a flat pattern, indicating no renal function; the renogram pattern was slightly delayed in the right kidney. The patient was transferred to our hospital for further examination on 21 September. Flomoxef sodium (1000 mg/day) was begun intravenously on 26 September and a single J catheter was inserted on 3 October. Soon after, necrotic tissue was observed in the urine through a drainage catheter, and renal papillary necrosis was diagnosed. The patient's clinical course is shown in Fig. 2 . After insertion of the catheter. the hydronephrosis diminished. but clubbing of the calices remained. and creatinine clearance and renal plasma flow remained low. The drainage catheter was removed on 16 October. Starting on 14 October. flomoxef sodium treatment was replaced by 40 mg/day prostaglandin EI' administered intravenously. and 300 mg/day norfloxacin was added orally for 14 days. Soon after the start of the prostaglandin E, and norfloxacin regime. creatinine clearance improved from 25 to 56 IIday (on 21 October) and renal plasma flow improved from 170 to 400 mllmin (on 6 November). The left-flank and back pain gradually improved and proteinuria and haematuria decreased. The renogram of the left kidney also returned to the normal pattern.
DISCUSSION
Renal papillary necrosis is a rare disease which is difficult to diagnose. Since RPN 92 occurs in association with various conditions, it is important to identify the underlying disorders. The most common condition associated with RPN is diabetes mellitus. accounting for approximately 60% of all cases of RPN in the USA.l.4 In Japan. the number of diabetic patients with RPN appears to be increasing." The patient in the present case had had diabetes mellitus for 10 years and her disease was complicated by diabetic retinopathy and neuropathy. It is known that the incidence of RPN is much higher when diabetic patients experience acute pyelonephritis.'; This patient's negative urine culture indicated. however. that pyelonephritis was unlikely. Considering these findings along with the absence of any history of analgesic abuse or sickle cell anaemia. diabetes mellitus itself seemed to be the most likely cause of RPN in this patient.
The most remarkable finding in the present case is that the use of prostaglandin E, improved renal function dramatically. Insertion of a single J catheter for the treatment of hydronephrosis and administration of antibiotics did not improve renal function but the levels of both renal plasma flow and creatinine clearance increased after intravenous infusion of prostaglandin E, was started.
Since prostaglandin E, is well known as a potent vasodilator. it is possible that the administration of prostaglandin E, improves renal microcirculation. improving renal ischaemia and/or preventing tissue injury. Several experimental and clinical reports describe the beneficial renal effects of prostaglandin E,. In an ischaemic acute renal failure model in rats/ dogs" and kidneytransplanted dogs," prostaglandin E\ could prevent increases in serum creatinine and decreases in vascular resistance. In enhanced vasoconstriction. for example after administration of indomethacin. noradrenaline. or cyclosporine, prostaglandin E 1 could increase creatinine clearance in the 
Clinical course of patient with diabetes mellitus complicated by renal papillary necrosis. RPF, renal plasma flow; Ccr, creatine clearance.
presence of decreased peripheral perfusion pressure. 10 -12 In clinical situations, treatment with prostaglandin E 1 increased glomerular filtration rate and creatinine clearance in patients with severe heart failure." In the present case, the administration of prostaglandin E 1 was clinically effective for RPN. In patients with RPN, a reduction in the number of vessels and thickening of the vascular wall in the renal medulla have been demonstrated using micro-angiography;" these authors suggested that medullary ischaemia is one of the most important 93 causative factors of RPN. It appears that prostaglandin E 1 is effective in improving renal circulation, which is likely to have deteriorated in patients with RPN. In addition, prostaglandin E 1 inhibits platelet aggregation15 and leukocyte activation, and has immunosuppressive properties." Okada et al," reported that prostaglandin E 1 reduced the level of proteinuria in patients with diabetic nephropathy. In the present case, proteinuria and haematuria were also diminished after the treatment with prostaglandin E 1 • While it appears that
